• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然化合物通过不同作用机制途径对三阴性乳腺癌的管理

Management of triple-negative breast cancer by natural compounds through different mechanistic pathways.

作者信息

Kaleem Mohammed, Thool Mandar, Dumore Nitin G, Abdulrahman Abdulrasheed O, Ahmad Wasim, Almostadi Amal, Alhashmi Mohammad Hassan, Kamal Mohammad Amjad, Tabrez Shams

机构信息

Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India.

Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, India.

出版信息

Front Genet. 2024 Jul 26;15:1440430. doi: 10.3389/fgene.2024.1440430. eCollection 2024.

DOI:10.3389/fgene.2024.1440430
PMID:39130753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11310065/
Abstract

Triple-negative breast cancer (TNBC) is the most severe form of breast cancer, characterized by the loss of estrogen, progesterone, and human epidermal growth factor receptors. It is caused by various genetic and epigenetic factors, resulting in poor prognosis. Epigenetic changes, such as DNA methylation and histone modification, are the leading mechanisms responsible for TNBC progression and metastasis. This review comprehensively covers the various subtypes of TNBC and their epigenetic causes. In addition, the genetic association of TNBC with all significant genes and signaling pathways linked to the progression of this form of cancer has been enlisted. Furthermore, the possible uses of natural compounds through different mechanistic pathways have also been discussed in detail for the successful management of TNBC.

摘要

三阴性乳腺癌(TNBC)是最严重的乳腺癌形式,其特征是雌激素、孕激素和人表皮生长因子受体缺失。它由多种遗传和表观遗传因素引起,预后较差。表观遗传变化,如DNA甲基化和组蛋白修饰,是导致TNBC进展和转移的主要机制。本综述全面涵盖了TNBC的各种亚型及其表观遗传原因。此外,还列举了TNBC与所有与这种癌症进展相关的重要基因和信号通路的遗传关联。此外,还详细讨论了天然化合物通过不同作用机制途径在成功治疗TNBC方面的可能用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/638b/11310065/1639bd83b5d6/fgene-15-1440430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/638b/11310065/d5c1774e8625/fgene-15-1440430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/638b/11310065/1639bd83b5d6/fgene-15-1440430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/638b/11310065/d5c1774e8625/fgene-15-1440430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/638b/11310065/1639bd83b5d6/fgene-15-1440430-g002.jpg

相似文献

1
Management of triple-negative breast cancer by natural compounds through different mechanistic pathways.天然化合物通过不同作用机制途径对三阴性乳腺癌的管理
Front Genet. 2024 Jul 26;15:1440430. doi: 10.3389/fgene.2024.1440430. eCollection 2024.
2
Epigenetics of Triple-Negative Breast Cancer via Natural Compounds.天然化合物介导的三阴性乳腺癌表观遗传学
Curr Med Chem. 2022 Mar 4;29(8):1436-1458. doi: 10.2174/0929867328666210707165530.
3
Epigenetic Regulation and Dietary Control of Triple Negative Breast Cancer.三阴性乳腺癌的表观遗传调控与饮食控制
Front Nutr. 2020 Sep 8;7:159. doi: 10.3389/fnut.2020.00159. eCollection 2020.
4
Potential epigenetic modifications implicated in triple- to quadruple-negative breast cancer transition: a review.三重至四阴性乳腺癌转化中潜在的表观遗传修饰:综述。
Epigenomics. 2022 Jun;14(11):711-726. doi: 10.2217/epi-2022-0033. Epub 2022 Apr 27.
5
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line.三阴性乳腺癌细胞系中的信号通路和天然化合物。
Molecules. 2022 Jun 7;27(12):3661. doi: 10.3390/molecules27123661.
6
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer.三阴性乳腺癌上皮-间质转化中表观遗传改变影响的新见解
Cancers (Basel). 2019 Apr 18;11(4):559. doi: 10.3390/cancers11040559.
7
Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.较高水平的基质金属蛋白酶组织抑制因子-1(TIMP-1)表达与三阴性乳腺癌的不良预后相关。
Mol Cancer. 2016 Apr 30;15(1):30. doi: 10.1186/s12943-016-0515-5.
8
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment.三阴性乳腺癌中的表观遗传调控:对肿瘤微环境的治疗意义
Pharmacol Res. 2024 Jun;204:107205. doi: 10.1016/j.phrs.2024.107205. Epub 2024 May 6.
9
Targeting Triple-Negative Breast Cancer by the Phytopolyphenol Carnosol: ROS-Dependent Mechanisms.植物多酚鼠尾草酸靶向三阴性乳腺癌:依赖活性氧的机制
Antioxidants (Basel). 2023 Jun 27;12(7):1349. doi: 10.3390/antiox12071349.
10
Compounds from diverse natural origin against triple-negative breast cancer: A comprehensive review.不同天然来源的化合物抗三阴性乳腺癌:全面综述。
Chem Biol Drug Des. 2023 Jan;101(1):218-243. doi: 10.1111/cbdd.14172. Epub 2022 Nov 15.

引用本文的文献

1
Silibinin Anticancer Effects Through the Modulation of the Tumor Immune Microenvironment in Triple-Negative Breast Cancer.水飞蓟宾通过调节三阴性乳腺癌肿瘤免疫微环境发挥抗癌作用。
Int J Mol Sci. 2025 Jun 28;26(13):6265. doi: 10.3390/ijms26136265.

本文引用的文献

1
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.皮肤癌治疗策略的综合综述
ACS Omega. 2024 Feb 22;9(9):10030-10048. doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5.
2
Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment.姜黄素、其衍生物及其纳米制剂:癌症治疗的革命。
Cell Biochem Funct. 2024 Jan;42(1):e3911. doi: 10.1002/cbf.3911.
3
In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.体外和体内姜黄素对乳腺癌的预防作用:DNMT1 的作用。
Molecules. 2024 Jan 16;29(2):434. doi: 10.3390/molecules29020434.
4
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.基于天然产物的抗癌药物发现:从计算方法到临床研究
Biomedicines. 2024 Jan 16;12(1):201. doi: 10.3390/biomedicines12010201.
5
Glyceollins from soybean: Their pharmacological effects and biosynthetic pathways.大豆中的甘草素:其药理作用及生物合成途径。
Heliyon. 2023 Nov 4;9(11):e21874. doi: 10.1016/j.heliyon.2023.e21874. eCollection 2023 Nov.
6
Anti-cancer effect of a phytochemical compound - 7R-acetylmelodorinol - against triple-negative breast cancer cells.植物化学化合物 7R-乙酰基美罗多醇对三阴性乳腺癌细胞的抗癌作用。
Biomed Pharmacother. 2023 Oct;166:115286. doi: 10.1016/j.biopha.2023.115286. Epub 2023 Aug 12.
7
Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells.血根碱诱导三阴性乳腺癌细胞凋亡和细胞周期阻滞涉及 AKT/PI3K 通路。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):323-342. doi: 10.21873/cgp.20385.
8
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.毛蕊异黄酮通过下调新型雌激素受体-α剪接变体 ER-α30 介导的 PI3K/AKT 信号通路抑制三阴性乳腺癌的进展。
Phytomedicine. 2023 Sep;118:154924. doi: 10.1016/j.phymed.2023.154924. Epub 2023 Jun 14.
9
Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling.木犀草素通过SGK1-FOXO3a-BNIP3信号通路诱导细胞凋亡和自噬来抑制三阴性乳腺癌。
Front Pharmacol. 2023 Jun 6;14:1200843. doi: 10.3389/fphar.2023.1200843. eCollection 2023.
10
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.新辅助 Talazoparib 治疗胚系 BRCA1/2 突变阳性、早期三阴性乳腺癌患者:一项 II 期研究结果。
Oncologist. 2023 Oct 3;28(10):845-855. doi: 10.1093/oncolo/oyad139.